Sumitomo Mitsui Trust Group Inc. Purchases 15,497 Shares of National Health Investors, Inc. (NYSE:NHI)

Sumitomo Mitsui Trust Group Inc. lifted its position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 478,900 shares of the real estate investment trust's stock after purchasing an additional 15,497 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 1.03% of National Health Investors worth $35,372,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Loomis Sayles & Co. L P increased its stake in National Health Investors by 42.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock valued at $44,000 after purchasing an additional 189 shares in the last quarter. GF Fund Management CO. LTD. acquired a new position in shares of National Health Investors during the fourth quarter valued at about $58,000. Jones Financial Companies Lllp increased its position in shares of National Health Investors by 781.2% during the fourth quarter. Jones Financial Companies Lllp now owns 890 shares of the real estate investment trust's stock worth $62,000 after acquiring an additional 789 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in shares of National Health Investors by 5,000.0% in the 1st quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock worth $68,000 after acquiring an additional 900 shares during the last quarter. Finally, NewEdge Advisors LLC bought a new position in National Health Investors in the 4th quarter valued at about $83,000. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Trading Up 1.5%

NYSE:NHI opened at $70.53 on Thursday. National Health Investors, Inc. has a 52 week low of $65.13 and a 52 week high of $86.13. The firm has a 50-day moving average price of $73.02 and a two-hundred day moving average price of $71.59. The company has a debt-to-equity ratio of 0.88, a quick ratio of 16.55 and a current ratio of 16.55. The firm has a market cap of $3.29 billion, a price-to-earnings ratio of 22.39, a price-to-earnings-growth ratio of 4.18 and a beta of 0.73.

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. The company had revenue of $68.87 million during the quarter, compared to the consensus estimate of $85.13 million. National Health Investors had a return on equity of 10.64% and a net margin of 41.15%. National Health Investors's revenue was up 9.6% on a year-over-year basis. During the same period last year, the business posted $1.10 earnings per share. On average, equities analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be issued a dividend of $0.90 per share. The ex-dividend date is Monday, June 30th. This represents a $3.60 dividend on an annualized basis and a yield of 5.10%. National Health Investors's dividend payout ratio (DPR) is presently 114.29%.

Wall Street Analyst Weigh In

NHI has been the subject of a number of recent research reports. Wedbush reissued an "outperform" rating and set a $88.00 price objective on shares of National Health Investors in a report on Monday, March 17th. Truist Financial raised National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 target price on the stock in a research report on Wednesday. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, National Health Investors presently has a consensus rating of "Moderate Buy" and an average price target of $85.75.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.